loratadine · Bayer Healthcare Llc · NDA 019658, 020641, 021891, 021952
Claritin
Earliest generic entry, as listed · earliest of 4 marketed strengths
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 4
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 019658 · 002 · RLD | tablet, oral | 10MG | open |
| 020641 · 002 · RLD | syrup, oral | 1MG/ML | open |
| 021891 · 002 · RLD | tablet, chewable, oral | 10MG | open |
| 021952 · 001 · RLD | capsule, oral | 10MG | open |